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Dystrophin, a gene product that is
mutated in individuals with
Duchenne muscular dystrophy, is
tethered to the extracellular matrix
via membrane-associated
multimolecular complexes. In
striated muscle cells this complex
contains two glycoprotein
subcomplexes, the sarcoglycan
(SG) and dystroglycan (DG)
complexes. Disruption of these
large transmembrane complexes
has been shown to result in
muscle disease. Altered
glycosylation of α-DG is
associated with two types of
congenital muscular dystrophy
[1,2] and mutations in the
α-DG–binding laminin α2 gene
product is linked to a third
congenital muscular dystrophy [3].
Mutations in α-SG (adhalin) and
ε-SG result in type 2D limb-girdle
muscular dystrophy (LGMD2D)
and myoclonus-dystonia
syndrome (a CNS disorder),
respectively [4,5].
The dystroglycan gene product
is cleaved post-translationally 
to yield two associated
glycoproteins [6]. α-DG
represents the highly 
glycosylated amino-terminal
portion, which binds several
extracellular molecules, whereas
the β-DG carboxy-terminal portion
spans the membrane and links to
the actin cytoskeleton via
dystrophin or its paralogue
utrophin. DG and α/ε-SG
homologues are known in other
vertebrates and invertebrates yet
their domain contents and
evolutionary heritages have not
been reported.
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Here we reveal that DG and
α/ε-SG sequences contain
cadherin domain homologues 
(see legend to Figure 1). In
animals, cadherin domain-
containing proteins are adhesion
molecules that modulate a wide
variety of processes including 
cell polarization and migration 
[7]. Our study also identified
cadherin domains in
Saccharomyces cerevisiae
Axl2p (also known as Sro4p 
and Bud10p) and several 
very large proteins from
magnetotactic bacteria.
The use of a predicted protein
from Magnetococcus MC1 was
critical to the discovery of the
αDG, α/ε-SG and Axl2p cadherin
domains. This sequence is
unusual in two respects. First, it
contains 11699 amino acids, 
when the mean length of a
bacterial sequence is
approximately 300 amino acids.
Second, it also contains integrin-
α-like β-propellers and laminin
G-like domains that are 
more typical of eukaryotic
extracellular proteins.
Axl2p, αDG, α/εSG and
cadherins are similar not only in
containing homologous domains,
but also in their cellular
localizations, functions and
posttranslational modifications.
Axl2p, DG, α/εSG and cadherins
are all type I transmembrane
proteins with their homologous
cadherin domains located in 
the extracellular environment.
Axl2p and cadherins also 
appear to be involved in
establishing cell polarity, albeit 
in different unicellular and
multicellular contexts [7,8].
Furthermore, disruption of
glycosylation of Axl2p and 
αDG causes dysfunction [6,9]
which, for αDG, results in 
muscle disease.
Crystal structures have revealed
that multiple cadherin domains
form Ca2+-dependent rod-like
structures with a conserved
Ca2+-binding pocket at the
domain–domain interface [10].
Multiple alignment of αDG, α/εSG,
Axl2p and bacterial cadherin
domain sequences with cadherin
domains of known structure
(Figure 1) show that most of the
Ca2+-binding residues in the
crystal structures are conserved.
This implies that the newly
identified cadherin domains may
associate via a Ca2+-dependent
association mechanism, by
forming homotypic or heterotypic
multimers. These predictions may
assist the rational design of 
DG- or α/ε-SG-binding drugs.
αDG represents an important
therapeutic target not only for 
its role in muscle disease, but 
also for its role as a cellular
receptor for Mycobacterium
leprae, the causative organism of
leprosy, and for Old World
arenaviruses [6].
The amino-terminal region
(amino acids 80–180) of αDG 
had previously been suggested to
belong to the immunoglobulin Κ
family [11]. This region overlaps
with the cadherin homology
domain (amino acids 58–158,
Figure 1. Multiple sequence alignment of cadherin domain homologues in dystrogly-
cans (upper five sequences), yeast Axl2p (four sequences), α/ε-sarcoglycans (four
sequences) and a Magnetococcus MC1 protein (contig 447 gene 7), represented using
CHROMA [14] and a 75% consensus.
Only a representative selection of cadherin domain homologues in the Magnetococcus
MC1 protein is shown. Amino acid residues with 80% or greater conservation are high-
lighted in black, and amino acids that form Ca2+-binding sites in cadherins are indicated
above the alignment with *. α-Sarcoglycan amino acids that are substituted in individ-
uals with type 2D limb-girdle muscular dystrophy are shown in red. Amino acids that
have been excised from the alignment have been replaced with numbers in parenthe-
ses. The known secondary structure of a mouse E-cadherin cadherin domain (PDB
code 1EDH) is shown beneath the alignment [10], as is the predicted [15] secondary
structure of dystroglycan-like cadherin domains.
The human dystroglycan sequence was compared using BLAST [16] with a protein
sequence database (nrdb+) containing predicted sequences from genome sequence
projects at www.vge.ac.uk/blast/psiblast.cgi. This comparison showed similarity
between dystroglycan and eight regions of a Magnetococcus MC1 protein (contig 447
gene 7, here called MC1-447-7) with significant E-values (2 × 10–4, 7 × 10–4, 5 × 10–3, 
2 × 10–2, 3 × 10–2, 9 × 10–2, 2 × 10–1, and 1.8). Analysis of MC1-447-7 using prospero [17]
initially revealed 45 domain repeats that encompassed the regions of similarity to
human dystroglycan.
Similar PSI-BLAST database searches using the DG-like domains in MC1-447-7 and an
E-value inclusion threshold of 2 × 10–3 revealed their significant sequence similarity to
Axl2p, cadherins and α-SG. For example, querying the database with amino acids
1888–1987 of MC1-447-7 revealed significant similarity with two regions of human DG
(round 2; E = 1 × 10–3 and 9.4 × 10–2), two regions of yeast Axl2p (round 3; E = 3 × 10–4
and 2.4), a cadherin domain in rat cadherin-17 (round 3; E = 2 × 10–3) and mouse α-SG
(round 3; E = 6 × 10–3). These similarities were further emphasized by a PSI-BLAST com-
parison of the human αSG sequence with nrdb+ which yielded significant similarity with
MC1-447-7 (round 2, E = 1 × 10–3; amino acids 688–773).
These evolutionary relationships were further emphasized following a PSI-BLAST
search of nrdb+ with the yeast Axl2p sequence. Seven cadherin domain-containing
regions of MC1-447-7 were detected as significantly similar with E < 1 × 10–4. These
similarities allowed delineation of 4 homologous domains in Axl2p, and further com-
parison of the MC1-447-7 sequence with hidden Markov models [18] derived from cad-
herin domain alignments revealed a total of at least 64 cadherin-homologous domains
in MC1-447-7.
Abbreviations: Ce, Caenorhabditis elegans; DG, dystroglycan; Dm, Drosophila
melanogaster; Hs, Homo sapiens; MC, Magnetococcus MC1; MC1447-7, Magnetococ-
cus MC1 protein (contig 447 gene 7); Mm, Mus musculus.
In descending order, the sequences’ GenInfo [GI] and amino acid numbers in paren-
theses are: 2498284 (62–163 and 498–602), 7302998 (654–756 and 885–986), 7508110
(241–338), 731878 (25–131, 146–251, 253–350 and 350–448), 13431858 (27–131),
13431835 (25–132), 7297374 (22–123), 7504958 (28–123), no GI code for the 
Magnetococcus MC1 protein (543–657, 2177–2277, 2635–2734, and 5084–5182), and
1942715 (114–220).
* * * *** * ***
alpha-DG  Hs 1 PTVVGIPDGT(5)SFRVTI-----PTDLI-ASSGDIIKVSAAGKEAL-PSWLHWDSQ---SHTLEG-LPLDTDK---GVHYISVSATRLGA(5)PQTSSVFSIEVYPEDHSD
alpha-DG  Hs 2 ELKNHIDRVD(5)YFEVKIP-SDTFYDHE-DTTTDKLKLTLKLRE(6)KSWVQFNSN---SQLMYG-LPDSSHV---GKHEYFMHATDKGG---LSAVDAFEIHVHRRPQGD
CG18250   Dm 1 IIKTRLQKLA(5)AFTFHVL-PETFYDAE---DQGNLRLALTDKD(6)NSWLQFNAD---KRELYG-LPLDDTV---SRWQYRLSATDSGN---ASVTETVEISVQQHRAVR
CG18250   Dm 2 MPRNQVDRVN(5)LLVYKVP-ADTFYDAN----DNQLTLTLKTRD(6)RHWLQFDSK---NEEFYG-IPKSGDI---GSEEYLLVAEDSGG---LSAHDALVVVVSPAPKRD
T21B6.1   Ce  ILLNRLPSFT(5)MCDLRIP-SETFKDAE---DGDTFKMKLSVLA(4)EVWMINESN----KGLIG-VPMRT-----GEFNYRLEARDKAG---QLASAPFQVNVKPALPTN
Axl2p  Sc 1 YEAYPIGKQY(8)SFTFQI-----SNDTY----KSSVDKTAQITY(5)PSWLSFDSS---SRTFSG-EPSSDLL(6)LYFNVILEGTDSAD--STSLNNTYQFVVTNRPSIS
Axl2p   Sc 2 GYTNGKNALK(5)VFNVTFD-RSMFTNEE----SIVSYYGRSQLY(4)PNWLFFDSG---ELKFTGTAPVINSA(4)TSYSFVIIATDIEG--FSAVEVEFELVIGAHQLTT
Axl2p   Sc 3 IQNSLIINVT(5)SYDLPLN--YVYLDDD------PISSDKLGSI(5)PDWVALDN-----ATISGSVPDELL----GKNSNPANFSVSIY-DTYGDVIYFNFEVVSTTDLF
Axl2p Sc 4 FAISSLPNIN(5)WFSYYFL-PSQFTDYV----NTNVSLEFTNSSQD-HDWVKFQSS---NLTLAGEVPKNFDK---LSLGLKANQGSQSQ---ELYFNIIGMDSKITHSNH
SGC-alpha Hs TLHPLVGRVF(6)ETFLSLP--EHVAVPP----AVHITYHAHLQG(4)PRWLRYTQR(4)PGFLYG-SATPEDR---GLQVIEVTAYNRDSF--DTTRQRLVLEIGDPEGPL
SGC-epsil Hs NVYPSAGVLF(7)YFKGEFPPYPKPGEIS----NDPITFNTNLMG(4)PGWLRYIQR(4)DGVLYG-SPTAENV--GKPTIIEITAYNRRTF--ETARHNLIINIMSAEDFP
CG7851    Dm KLQANVGE-----LFTYKIE-PQLFNWTH-QVISQQFRYRPSLKN(4)PSWMRYMYS(4)AGFLYG-TPPASSA--GKDLSLDVVALNRQNY--ETRRVVVTMFVAHKFPTP
H22K11.4  Ce HVTATKGK-----FFVHTLH-SAHFFPS-----TVKVKWEATLNK(4)PNWLRLLPS(4)IAYLIG-TPVTNV----QHVTLHVIAKRLDNF--DIQQRMVVINLVEDSLYQ
MC1447-7  MC 1  TLTNEESLEV(5)QVQIALN-SALFTDVD---SNDTLTWTATLEN(4)PSWIRFVDLD-GVQTLVT-EPTYGDG(4)QSFTLHLTAHDASG(8)TATYKTLTITTRDPNNIP
MC1447-7  MC 11 TKNVDIADQL(5)AYNLTLS-ASGFTDVD---SGDSLSYSVSALA(4)PSWLSFDAD---TRTFTG-LASSSDV---GVFGVKVTVTDSSG---ATAYDSFNITVQAPNNAP
MC1447-7  MC 12 GIFTTTEGNP(6)SFSYSVAMSDITSDSS------ATTMSVTQID(4)PSWINFDTQ---SFTFTG-TPTNDDV---GSIALKLVAKDSAG--TTLGSKIATLEVVNYNDTP
MC1447-7  MC 21 TLVSTISVDA(5)TATFSV--ASFFTDAN----SDTLVYSATLLD(4)PSWISFDTN---TATFSG-TPLNAHV---GSMALKVTATDPQG---LSVSGNFQLAILNSNDAP
1EDH   Mm   VFEGSVAEGA(3)TSVMKVS----ATDAD(5)YNAAIAYTIVSQD(5)KNMFTVNRD---TGVISV-LTSGLDRESYPTYTLVVQAADLQGE-GLSTTAKAVITVKDINDNA
Consensus/75%  hh.s.hs.......hpbpl.....hh-......ss.lpbphp.b.....sWlpapsp.....hb.G.hP.s.....h..b.b.l.A.s..s.....s...h.l.l.......
2D (1EDH) EEEEEEE EEEE EE EEEEEEEE EEE EEEE EEEEEEEEEHHHH EEEEEEEEEEEE
2D (DG-like) eEEE eEEEEE eeEe eEEEEEEe eeEEEe EEEE eeEEEEEEEEe EEEEEEEEEEE
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approximately) identified 
here. The carboxy-terminal
cadherin domain of αDG 
(amino acids 493–597,
approximately) has a
protein-binding function. 
It coincides with the αDG regions
(amino acids 485–651 and
494–653, respectively) that bind
βDG and the leucine-rich repeat
proteoglycan biglycan [12,13].
The cadherin domain in αSG 
is the location of 16 out of 28
known mis-sense mutations that
result in type 2D limb-girdle
muscular dystrophy (Figure 1). 
As cadherin domains often are
involved in protein–protein
interactions it is likely that the
α/εSG cadherin domains function
by associating with other
molecules of the
dystrophin–glycoprotein
complexes. Mapping the 
16 amino acid substitutions 
onto cadherin crystal structures
shows that they all lie within, 
or at the ends of, β-strands
(Figures 1 and 2). This implies 
that these mutations are likely 
to disrupt the structure or folding
of this domain. The exceptions 
to this are replacements of
arginines with both histidine 
and cysteine at two distinct
positions (R34→His, R34→Cys;
R98→His, R98→Cys) which map
onto Ca2+-binding sites in
cadherin structures (Figure 2). 
It is possible therefore, that 
these substitutions abrogate an
α-sarcoglycan Ca2+-binding
function. These findings are 
likely to assist in the
understanding of DG and 
α/ε-SG functions, and their 
roles in muscle and CNS 
disease.
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Figure 2. Representation of the three-
dimensional structure of a cadherin
domain from mouse E-cadherin [10] (PDB:
1EDH), created using the SwissPDB
viewer (www.expasy.org/spdb).
β-strands are shown in yellow and loops
are shown in grey. Residues that
contact Ca2+ ions in the crystal structure
are shown in full and are coloured
according to the CPK scheme. Disease-
associated amino acids that are substi-
tuted due to mutations in the
α-sarcoglycan gene have been mapped
onto the cadherin domain structure
according to the alignment in Figure 1;
their positions in the structure are
shown in red. The majority of α-sarco-
glycan substitutions are within the cad-
herin β-sheets, although Arg34, Asp97
and Arg98, which are mapped to Ca2+-
binding regions, are in loop regions.
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